Smad2 transduces common signals from receptor serinethreonine and tyrosine kinases

Genes and Development

Volumn 12, Issue 11, 1998, Pages 1587-1592

  De Caestecker, Mark P ^a   Parks, W Tony ^a   Frank, Chistopher J ^a   Castagnino, Paola ^a   Bottaro, Donald P ^a   Roberts, Anita B ^a   Lechleider, Robert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HGF; Protein phosphorylation; Receptor kinases; Signal transduction; SMAD; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SCATTER FACTOR;

ARTICLE; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 2642605344     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.11.1587     Document Type: Article

References (38)

1. Abdollah, S., M. Macias-Silva, T. Tsukazaki, H. Hayashi, L. Attisano, and J.L. Wrana. 1997. TβR-I phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272: 27678-27685.
2. Abe, M., J.G. Harpel, C.N. Metz, I. Nunes, D.J. Loskutoff, and D.B. Rifkin. 1994. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216: 276-284.
3. Cantley, L.C. and Z. Songyang. 1997. Specificity in protein-tyrosine kinase signaling. Adv. Second Messenger Phosphoprotein Res. 31: 41-48.
4. Chen, X., E. Weisberg, V. Fridmacher, M. Watanabe, G. Naco, and M. Whitman. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389: 85-89.
5. Cioce, V., K.G. Csaky, A.M.L. Chan, D.P. Bottaro, W.G. Taylor, R. Jensen, S.A. Aaronson, and J.S. Rubin. 1996. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J. Biol. Chem. 271: 13110-13115.
6. Coolican, S.A., D.S. Samuel, D.Z. Ewton, F.J. McWade, and J.R. Florini. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272: 6653-6662.
7. de Caestecker, M.P., P. Hemmati, S. Larisch-Bloch, R. Ajmera, A.B. Roberts, and R.J. Lechleider. 1997. Characterization of functional domains within Smad4/DPC4. J. Biol Chem. 272: 13690-13696.
8. de Winter, J.P., B.A. Roelen, P. ten Dijke, B. van der Burg, and A.J. van den Eijnden-van Raaij. 1997. DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 14: 1891-1899.
9. Frenz, D.A., W. Liu, J.D. Williams, V. Hatcher, V. Galinovic-Schwartz, K.C. Flanders, and T.R. Van de Water. 1994. Induction of chondrogenesis: Requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-β. Development 120: 415-424.
10. Hartsough, M.T., R.S. Frey, P.A. Zipfel, A. Buard, S.J. Cook, F. McCormick, and K.M. Mulder. 1996. Altered transforming growth factor signaling in epithelial cells when ras activation is blocked. J. Biol. Chem. 271: 22368-22375.
11. Hayashi, H., S. Abdollah, Y. Qiu, I. Cai, Y.Y. Xu, B.W. Grinnell, M.A. Richardson, J.N. Topper, M.A. Gimbrone Jr., J.L. Wrana, and D. Falb. 1997. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 89: 1165-1173.
12. Heldin, C.H., K. Miyazono, and P. ten Dijke. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
13. Keski-Oja, J., R. Raghow, M. Sawdey, D.J. Loskutoff, A.E. Postlethwaite, A.H. Kang, and H.L. Moses. 1988. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-β. Divergent responses in lung fibroblasts and carcinoma cells. J. Biol. Chem. 263: 3111-3115.
14. Kim, J., K. Johnson, H.J. Chen, S. Carroll, and A. Laughon. 1997. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388: 304-308.
15. Kretzschmar, M., J. Doody, and J. Massagué. 1997a. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389: 618-622.
16. Kretzschmar, M., F. Liu, A. Hata, J. Doody, and J. Massagué. 1997b. The TGF-β family mediator Smadl is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes & Dev. 11: 984-995.
17. Lagna, G., A. Hata, A. Hemmati-Brivanlou, and J. Massagué. 1996. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383: 832-836.
18. Laiho, M., M.B. Weis, and J. Massagué. 1990. Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265: 18518-18524.
19. Lechleider, R.J., M.P. de Caestecker, A. Dehejia, M.H. Polymeropoulos, and A.B. Roberts. 1996. Serine phosphorylation, chromosomal localization, and transforming growth factor-β signal transduction by human bsp-1. J. Biol. Chem. 271: 17617-17620.
20. Liu, F., A. Hata, J.C. Baker, J. Doody, J. Carcamo, R.M. Harland, and J. Massagué. 1996. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381: 620-623.
21. Liu, F., C. Pouponnot, and J. Massagué. 1997. Dual role of the Smad4/ DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes. Genes & Dev. 11: 3157-3167.
22. Lough, J., M. Barron, M. Brogley, Y. Sugi, D.L. Bolender, and X. Zhu. 1996. Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogenesis in non-precardiac embryonic mesoderm. Dev. Biol. 178: 198-202.
23. Macias-Silva, M., S. Abdollah, P.A. Hoodless, R. Pirone, L. Attisano, and J.L. Wrana. 1996. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215-1224.
24. Massagué, J. 1996. TGFβ signaling: Receptors, transducers, and Mad proteins. Cell 85: 947-950.
25. Nakao, A., E. Roijer, T. Imamura, S. Souchelnytskyi, G. Stenman, C.H. Heldin, and P. ten Dijke. 1997. Identification of Smad2, a human Mad-related protein in the transforming growth factor β signaling pathway. J. Biol. Chem. 272: 2896-2900.
26. Niswander, L. and G.R. Martin. 1993. FGF-4 and BMP-2 have opposite effects on limb growth. Nature 361: 68-71.
27. Pawson, T. 1995. Protein modules and signalling networks. Nature 373: 573-580.
28. Rahimi, N., E. Tremblay, and B. Elliott. 1996. Phosphatidylinositol 3-kinase activity is required for hepatocyte growth factor-induced mitogenic signals in epithelial cells. J. Biol. Chem. 271: 24850-24855.
29. Roberts, A.B., C.A. Frolik, M.A. Anzano, and M.B. Sporn. 1983. Transforming growth factors from neoplastic and nonneoplastic tissues. Fed. Proc. 42: 2621-2626.
30. Souchelnytskyi, S., K. Tamaki, U. Engstrom, C. Wernstedt, P. ten Dijke, and C.H. Heldin. 1997. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J. Biol. Chem. 272: 28107-28115.
31. Stern, H.M., J. Lin-Jones, and S.D. Hauschka. 1997. Synergistic interactions between bFGF and a TGF-β family member may mediate myogenic signals from the neural tube. Development 124: 3511-3523.
32. Stolz, D.B. and G.K. Michalopoulos. 1997. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-β 1 in vitro. J. Cell Physiol. 170: 57-68.
33. Traverse, S., N. Gomez, H. Paterson, C. Marshall, and P. Cohen. 1992. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288: 351-355.
34. Wojta, J., T. Nakamura, A. Fabry, P. Hufnagl, R. Beckmann, K. McGrath, and B.R. Binder. 1994. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells. Blood 84: 151-157.
35. Yamaguchi, K., K. Shirakabe, H. Shibuya, K. Irie, O. Isao, N. Ueno, T. Yaniguchi, E. Nishida, and K. Matsumoto. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270: 2008-2112.
36. Yan, Z., S. Winawer, and E. Friedman. 1994. Two different signal transduction pathways can be activated by transforming growth factor β 1 in epithelial cells. J. Biol. Chem. 269: 13231-13237.
37. Yingling, J.M., M.B. Datto, C. Wong, J.P. Frederick, N.T. Liberati, and X.F. Wang. 1997. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol. Cell Biol. 17: 7019-7028.
38. Zhang, Y., T. Musci, and R. Derynck. 1997. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr. Biol. 7: 270-276.